ArticleLeukemia2026

BTK inhibitors are associated with a lower risk of myeloid neoplasms and non-melanoma skin cancer compared with chemoimmunotherapy in chronic lymphocytic leukemia: a propensity score-matched analysis.

Pratik Shah et al.PubMed ↗Publisher ↗

No numbers read from the abstract.